No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of argatroban to intravenous alteplase did not improve neurologic outcomes in patients with acute ischemic stroke

byZain Cheema

May 1, 2023

in StudyGraphics

Reading Time: 1 min read

Pegylated interferon lambda reduces the risk of COVID-19-related hospitalization

RelatedReports

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Neurology

Tenecteplase (TNKase) may worsen functional outcomes in older patients with minor ischemic stroke

April 24, 2026

Abusive head trauma results in fewer productive life-years

Cardiology

Asundexian may reduce recurrent ischemic stroke without increased bleeding risk

April 20, 2026

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Hypotonic IVF linked to increased risk of hyponatremia

Early restrictive fluid management does not reduce mortality in sepsis-induced hypotension

Quick Take: Association of African Ancestry with Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study

NT-proBNP associated with risk for incident heart failure and all-cause mortality

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

2 Minute Medicine Rewind February 20, 2023

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports